Next Capital Management’s Novartis NVS Stock Holding History

Next Capital Management’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-1,000	Closed	-$87K	–	172
2019 Q3	$87K	Sell	1,000 -655	-40%	-$58.8K	0.06%	114
2019 Q2	$151K	Buy	1,655 +539	+48%	+$45.6K	0.1%	95
2019 Q1	$96K	Hold	1,116	–	–	0.08%	112
2018 Q4	$86K	Buy	+1,116	New	+$86.9K	0.08%	108

Other funds holding NVS

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Mawer Investment Management Calgary, Alberta, Canada $15.4B AUM 10.9% 1-Year Est. Return

Next Capital Management's NVS Position: Q4 2019 in Review

Next Capital Management sold out of Novartis (NVS) in Q4 2019, closing a stake of 1,000 shares — an estimated $87K sold.

Next Capital Management first reported a position in NVS in Q4 2018 and held it in 4 quarters. The position peaked at $151K in Q2 2019. 1,172 funds tracked by Wall St. Rank hold NVS as of Q4 2019.

Next Capital Management reported no remaining Novartis position as of Q4 2019 after selling out during the quarter.
Next Capital Management sold 1,000 Novartis shares in Q4 2019, an estimated $87K.
Next Capital Management first reported a position in Novartis in Q4 2018 and held it in 4 quarters.
Next Capital Management's Novartis position peaked at $151K in Q2 2019.
1,172 funds tracked by Wall St. Rank held Novartis as of Q4 2019.

Based on Next Capital Management's 13F filing for Q4 2019, filed 12 Feb 2020.